Orexo
Uppsala
About Orexo
Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $129.4M
- Funding stage: IPO
- Last round: Grant (Sep 2025)
- Ticker: sto:ORX
- Website: orexo.com
- Phone: 46 1 87 80 88 00
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/orexo-5527 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.